Compare Marqeta Inc (MQ) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs 10X Genomics Inc — how do they compare? Marqeta Inc trades at $15.52 (market cap $1.62B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 4.7× Marqeta Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Marqeta Inc nearer its low. Which is the better fit depends on your goals.
| MQ | TXG | |
|---|---|---|
Market Cap | $1.62B | $7.61B |
Sector | Technology | Health |
52-Week High | $26.00 | $58.57 |
52-Week Low | $15.04 | $11.34 |
Enterprise Value | $935.36M | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
